Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response
about
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cellsProteomics for biodefense applications: progress and opportunities.Proteomics in cancer vaccine development.Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.A novel strategy for the targeted analysis of protein and peptide metabolitesUse of proteomics to define targets of T-cell immunity.The potential of proteomics and peptidomics for allergy and asthma research.Determination of protein-derived epitopes by mass spectrometry.MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell responseMajor histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.The insulin A-chain epitope recognized by human T cells is posttranslationally modifiedCancer immunomics using autoantibody signatures for biomarker discovery.Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.Contributions to our understanding of T cell physiology through unveiling the T cell proteome.Application of proteomic technology in eye research: a mini review.Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development.Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.Developing antibacterial vaccines in genomics and proteomics era.Impact of glycans on T-cell tolerance to glycosylated self-antigens.MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines.Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.Application of "Omics" Technologies for Diagnosis and Pathogenesis of Neurological Infections.Exploration of peptides bound to MHC class I molecules in melanoma.Immunomic approaches for antigen discovery of human parasites.Proteomics Tracing the Footsteps of Infectious Disease.Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure?Stable isotope shifted matrices enable the use of low mass ion precursor scanning for targeted metabolite identification.Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection.The turnover kinetics of major histocompatibility complex peptides of human cancer cells.Antigen Processing of a Short Viral Antigen by Proteasomes
P2860
Q28710385-54144A8F-46D4-4A2F-B914-F8350806D93BQ33215043-9CA3305E-69E8-448E-A7A1-8096CAD05505Q33215044-00DE1E43-CD05-40AD-B223-F74634C40247Q33222048-CB13FF6C-D4D4-486E-9903-0EF1D5B31308Q33895858-681E9DE4-4B62-4012-BC16-A76A056291BEQ35206861-0EEB32DA-19FA-4AA2-A4A7-F67D07A0C825Q36112076-048FD116-FD03-402B-9799-EF938A243F2BQ36184807-E4A88E65-25F0-4747-8993-6C24D74BA533Q36245780-949C0541-6399-4060-A978-843AD0F4B392Q36279073-48FE9A82-744F-486E-92E7-A2370063FC15Q36381178-3BD6ACAB-CA61-426F-B99E-09312E662A85Q36386903-6759BFA6-192E-4A08-8F65-E133CBE6B4DBQ36403698-1EA5FEB7-EE15-414A-AF01-30AF00294EDBQ36766125-D2157E21-A127-4B49-880B-88973CD64C3FQ36795668-C8E3D8D7-3807-4FE9-87FC-08822D2E624DQ36815232-903DE763-C93B-43F9-9BED-81B08E310E41Q37018105-1B105BA7-86C7-43BA-80AB-E1720BEE8B11Q37035272-2BBF0F04-CAB8-4E5A-8489-AD6380655709Q37108161-206F2164-A721-475D-B364-83F669A3BCFFQ37132297-EA445F04-3F14-4E6E-BEAB-2F6FDA6D3E63Q37216317-1210C027-6217-4FED-B60E-EF77B4BB6D8CQ37709626-2E155D8B-E717-4C91-8448-4838B9E7ABEAQ38547265-F6DF3A10-3619-4F54-96B9-24A13B56A09AQ38551782-E748FE99-6531-43DD-9C28-EE99978DA9BBQ38913724-BEC5413A-75D3-4701-8047-5AF78E06366DQ38989213-C7FD3F70-8086-4876-ABD7-E878C536FC74Q39120670-F11C9AC7-525F-4E8B-88A1-2922E6E308B4Q41840580-D000FAF7-A307-440E-B74F-5615AFD5D6BCQ42578731-D09B6A19-CF24-4B53-89DC-2C66FE6A3C8DQ43882094-EE6C3B60-7B5E-4193-9C6E-3E5767169D7BQ53650261-9D33F56D-2F63-4502-B085-DFC2A412FD47Q57593732-79BB8BC2-DEB2-4D66-BC31-B5BB35FDAE75
P2860
Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Immunoproteomics: Mass spectro ...... targets of the immune response
@ast
Immunoproteomics: Mass spectro ...... targets of the immune response
@en
Immunoproteomics: Mass spectro ...... targets of the immune response
@nl
type
label
Immunoproteomics: Mass spectro ...... targets of the immune response
@ast
Immunoproteomics: Mass spectro ...... targets of the immune response
@en
Immunoproteomics: Mass spectro ...... targets of the immune response
@nl
prefLabel
Immunoproteomics: Mass spectro ...... targets of the immune response
@ast
Immunoproteomics: Mass spectro ...... targets of the immune response
@en
Immunoproteomics: Mass spectro ...... targets of the immune response
@nl
P2860
P1476
Immunoproteomics: Mass spectro ...... targets of the immune response
@en
P2093
P2860
P304
P356
10.1074/MCP.R300013-MCP200
P407
P577
2004-01-12T00:00:00Z